O22 3D printed polyethylene oxide oral doses with innovative ‘radiator-like’ design: impact of molecular weight on mechanical and rheological properties and drug release

Abstract

BackgroundDespite regulatory advances, lack of age-appropriate formulations (AAFs) remains a challenge in paediatric practice. 3D-printing of oral dosage forms (ODFs) offers potential for AAFs for children. Optimising drug release from 3D-printed ODFs is an important technological step. Despite the abundant use of polyethylene oxides (PEOs) and their extensive use as an excipient, there have been no previous reports of applying this thermoplastic polymer species alone to fused deposition modelling (FDM) 3D printing. We assessed the impact of polymer molecular weight (MW) on the mechanical properties of the resultant filaments and their rheological properties. In the FDM 3D printing process, we also tested the effect of an innovative radiator-like design of the ODF on the acceleration of drug release patterns.MethodsBlends of PEO (MW: 100K, 200K, 300K, 600K or 900K) with PEG 6K (plasticiser) and a model drug (theophylline) were prepared by hot-melt extrusion. The resultant filaments were used as a feed for a FDM 3D printer to fabricate innovative designs of ODFs in a radiator-like geometry with inter-connected paralleled plates and inter-plate spacing of either 0.5mm, 1mm, 1.5mm or 2mm.ResultsVarying blends of PEO and PEG allowed formation of mechanically resistant filaments (maximum load at break of 357, 608, 649, 882, 781 N for filament produced with 100K, 200K, 300K, 600K or 900K, respectively). Filaments of PEO at a MW of 200K-600K were compatible with FDM 3D printing. Further increase in PEO MW resulted in elevated shear viscosity (>104 Pa.S) at the printing temperature and hindered material flow during FDM 3D printing. A minimum spacing (1 mm) between parallel plates of the radiator-like design was essential to boost drug release from the structure.ConclusionThese findings are essential in the development of next-generation personalised drug delivery doses using specialised polymer/polymer blends purposely optimised for FDM 3D printing.Disclosure(s)Nothing to disclose

3D Printed Tablets (Printlets) with Braille and Moon Patterns for Visually Impaired Patients

“…At present, 3D printing is often used to produce engineering prototypes due to its fast production speed and cost-effectiveness [20][21][22][23]. In the field of drug delivery, diverse constructs were already prepared using 3D printing ranging from drug-eluting implants [24][25][26][27] to medical devices [28][29][30], and personalised solid oral dosage forms [31][32][33][34][35][36][37][38][39]. In particular, 3D printing was shown to offer novel solutions to problems faced by specific patient groups [40][41][42][43][44].…”

3D printed opioid medicines with alcohol-resistant and abuse-deterrent properties

“…In this regard, three-dimensional printing (3DP) offers a novel manufacturing tool to fabricate such products. 3DP is an additive manufacturing technology (Trenfield et al, 2020), which in the arena of pharmaceutical field has the benefit of providing accurate dosing individualised to the patient (Awad et al, 2018a;Gioumouxouzis et al, 2018;Goyanes et al, 2019b;Goyanes et al, 2017;Peak et al, 2019;Pietrzak et al, 2015;Scoutaris et al, 2018;Trenfield et al, 2019a;Xu et al, 2020). Currently, the most commonly used 3DP technology in the preparation of pharmaceuticals is fused deposition modelling (FDM) (Awad et al, 2018b;Solanki et al, 2018).…”